全文获取类型
收费全文 | 1421篇 |
免费 | 76篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 31篇 |
妇产科学 | 17篇 |
基础医学 | 130篇 |
口腔科学 | 23篇 |
临床医学 | 127篇 |
内科学 | 519篇 |
皮肤病学 | 9篇 |
神经病学 | 90篇 |
特种医学 | 18篇 |
外科学 | 231篇 |
综合类 | 7篇 |
预防医学 | 87篇 |
眼科学 | 6篇 |
药学 | 83篇 |
中国医学 | 2篇 |
肿瘤学 | 111篇 |
出版年
2023年 | 7篇 |
2022年 | 16篇 |
2021年 | 36篇 |
2020年 | 22篇 |
2019年 | 15篇 |
2018年 | 27篇 |
2017年 | 18篇 |
2016年 | 27篇 |
2015年 | 23篇 |
2014年 | 43篇 |
2013年 | 54篇 |
2012年 | 60篇 |
2011年 | 97篇 |
2010年 | 48篇 |
2009年 | 49篇 |
2008年 | 71篇 |
2007年 | 102篇 |
2006年 | 75篇 |
2005年 | 73篇 |
2004年 | 77篇 |
2003年 | 65篇 |
2002年 | 59篇 |
2001年 | 41篇 |
2000年 | 32篇 |
1999年 | 20篇 |
1998年 | 12篇 |
1997年 | 5篇 |
1996年 | 6篇 |
1995年 | 11篇 |
1994年 | 9篇 |
1993年 | 12篇 |
1992年 | 24篇 |
1991年 | 15篇 |
1990年 | 26篇 |
1989年 | 23篇 |
1988年 | 24篇 |
1987年 | 19篇 |
1986年 | 21篇 |
1985年 | 10篇 |
1984年 | 8篇 |
1983年 | 20篇 |
1982年 | 5篇 |
1980年 | 6篇 |
1979年 | 9篇 |
1978年 | 19篇 |
1977年 | 15篇 |
1975年 | 6篇 |
1970年 | 4篇 |
1968年 | 5篇 |
1966年 | 5篇 |
排序方式: 共有1503条查询结果,搜索用时 15 毫秒
61.
Takako Yamamoto Yasuyuki Nakamura Atsushi Hozawa Tomonori Okamura Takashi Kadowaki Takehito Hayakawa Yoshitaka Murakami Yoshikuni Kita Akira Okayama Robert D Abbott Hirotsugu Ueshima 《Circulation journal》2008,72(4):545-550
BACKGROUND: Some studies focusing on low-risk profiles for cardiovascular disease have been reported in Western countries. Yet, few reports have examined, with substantial longevity, the low-risk profile for cardiovascular disease in the Japanese population. This study examines whether having a favorable risk factor profile yields lower all-cause mortality and whether the proportion of those with a low-risk profile is larger in the Japanese population. METHODS AND RESULTS: A total of 8,339 men and women aged 30-69 years without a history of cardiovascular diseases for 19 years, who had participated in the 1980 National Survey on Circulatory Disorders after being randomly selected from throughout Japan, were followed. Low risk was defined as having all of the following baseline characteristics: blood pressure (BP) <120/80 mmHg; no antihypertensive medication; serum cholesterol 160-240 mg/dl (4.14-6.22 mmol/L); no history of diabetes; and non-smoker. The long-term mortality of the low-risk group was compared with that of others using the Cox proportional hazard model. The prevalence of low risk was 9.4% of all participants. The multivariate-adjusted hazard ratios for low-risk individuals compared with others were as follows: 0.33 (95% confidence intervals (CI), 0.15-0.74) for cardiovascular disease and 0.63 (95% CI, 0.46-0.88) for all-cause mortality. The most attributable risk factor for all-cause mortality was high BP (>or=120/80 mmHg). CONCLUSION: Japanese individuals with favorable cardiovascular disease risk profiles had lower mortality from cardiovascular disease and all-causes than those without. 相似文献
62.
Yukio Kobayashi Kensei Tobinai Akihiro Takeshita Kensuke Naito Osamu Asai Nobuaki Dobashi Shinpei Furusawa Kenji Saito Kinuko Mitani Yasuo Morishima Michinori Ogura Fumiaki Yoshiba Tomomitsu Hotta Masami Bessho Shin Matsuda Jin Takeuchi Shuichi Miyawaki Tomoki Naoe Noriko Usui Ryuzo Ohno 《International journal of hematology》2009,89(4):460-469
The primary objective of this study was to investigate the tolerability, efficacy and pharmacokinetic profile of gemtuzumab
ozogamicin (GO) in patients with relapsed and/or refractory CD33-positive acute myeloid leukemia (AML). Patients received
2-h infusions of GO twice with an interval of approximately 14 days. Tolerability was assessed using the National Cancer Institute
Common Toxicity Criteria Version 2.0. Samples for pharmacokinetics were taken on day 1 and day 8 of the first treatment cycle.
The dose was increased stepwise and, in each cohort, patients were treated at the same dose. Forty patients, median age 58 years
(range 28–68) were treated; 20 and 20 patients were enrolled to the phase I and II parts, respectively. In the phase I part,
dose-limiting toxicities (DLTs) were hepatotoxicities, and the recommended dose was established as 9 mg/m2 given as two intravenous infusions separated by approximately 14 days. The pharmacokinetic study revealed that C
max and AUC were equivalent to those of non-Japanese patients. In the phase II part, complete remission was observed in 5 patients,
and one patient had complete remission without platelet recovery. Four of these 6 in remission and one in the phase I are
long-term survivors (alive for at least 44 months). GO is safe and effective as a single agent among Japanese CD33-positive
AML patients. Remission lasted longer in a subset of patients than in non-Japanese patients in earlier studies. Further studies
of this agent are warranted to establish standard therapy.
S. Furusawa: deceased. 相似文献
63.
Diabetes and osteoporosis 总被引:1,自引:0,他引:1
Since Albright first proposed the concept of "diabetic osteopenia", many studies have investigated the levels of bone mineral density (BMD) and the risk of osteoporosis in type 1 and type 2 diabetes. The presence of osteoporosis in type 1 diabetes seems to be a reliable evidence. On the other hand, there is still some controversy about the risk of osteoporosis in type 2 diabetes probably due to different pathogenesis, clinical stage and environmental factors. Although details of the pathogenic mechanisms are not fully understood, low insulin secretion, insulin resistance, hyperglycemia, adipocytokines and other diabetic complications including diabetic triopathy may determine changes in diabetic bone metabolism. Recent findings suggest that several drugs for life style-related disease such as statins, beta blockers and thiazolidinediones may have a potential role to promote bone formation other than their own therapeutic effects. 相似文献
64.
Okamura T Tanaka T Yoshita K Chiba N Takebayashi T Kikuchi Y Tamaki J Tamura U Minai J Kadowaki T Miura K Nakagawa H Tanihara S Okayama A Ueshima H;HIPOP-OHP research group 《Journal of human hypertension》2004,18(1):9-16
The purpose of this study was to clarify the effects of popular Japanese alcoholic beverages on blood pressure. We performed a cross-sectional study on 4335 Japanese male workers using baseline data from an intervention study. We defined six groups according to the type of alcoholic beverage that provided two-thirds of the subject's total alcohol consumption: beer, sake (rice wine), shochu (traditional Japanese spirits), whiskey, wine and others. The partial regression coefficients of daily alcohol intake (1 drink=11.5 g of ethanol) to systolic blood pressure (SBP) and diastolic blood pressure (DBP) were 0.87(P<0.001, standard error (s.e.)=0.09) and 0.77(P<0.001, s.e.=0.06), respectively. A comparison among the types of alcoholic beverages mainly consumed revealed significant differences in SBP and DBP. Both SBP and DBP were highest in the shochu group. However, an analysis of covariance adjusting for total alcohol consumption resulted in the disappearance of these differences. Although after adjustment for total alcohol consumption, the shochu group exhibited a significant positive association with 'high-normal blood pressure or greater' (odds ratio 1.43, 95% confidence interval 1.06-1.95) compared with the beer group, this significant relation disappeared after adjusting for the body mass index (BMI), urinary sodium and potassium excretion. The pressor effect, per se, of popular Japanese alcoholic beverages on blood pressure may not be different among the types of alcoholic beverages after adjusting for other lifestyle factors. 相似文献
65.
CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells 总被引:2,自引:0,他引:2
Harata M Soda Y Tani K Ooi J Takizawa T Chen M Bai Y Izawa K Kobayashi S Tomonari A Nagamura F Takahashi S Uchimaru K Iseki T Tsuji T Takahashi TA Sugita K Nakazawa S Tojo A Maruyama K Asano S 《Blood》2004,104(5):1442-1449
Patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+) ALL) have poor prognosis despite intensive therapeutic intervention. Recently, imatinib, a BCR-ABL tyrosine kinase inhibitor, has been proven to be an effective treatment for Ph(+) ALL, but nearly all patients rapidly acquire resistance. High-dose imatinib administration might overcome this resistance; however, systemic toxicities would likely limit this approach. Therefore, a new delivery system allowing for the specific targeting of imatinib is urgently needed. Because almost all Ph(+) ALL cells express CD19 on their surface, we have developed an immunoliposome carrying anti-CD19 antibody (CD19-liposomes). The internalization efficiency of the CD19-liposomes approached 100% in all Ph(+) ALL cells but was very low in CD19(-) cells. The cytocidal effect of imatinib-encapsulated CD19-liposomes (imatinib-CD19-liposomes) on Ph(+) ALL cell lines and primary leukemia cells from patients with Ph(+) ALL was much greater than that of imatinib with or without control liposomes. Importantly, the imatinib-CD19-liposomes did not affect the colony formation of CD34(+) hematopoietic cells, even at inhibitory concentration of free imatinib. Taken together, these data clearly demonstrate that the imatinib-CD19-liposomes induced specific and efficient death of Ph(+) ALL cells. This new therapeutic approach might be a useful treatment for Ph(+) ALL with fewer side effects than free imatinib. 相似文献
66.
Yoichi Sakurai Shingo Kamoshida Shinpei Furuta Risaburo Sunagawa Kazuki Inaba Jun Isogaki Yoshiyuki Komori Ichiro Uyama Yutaka Tsutsumi 《Gastric cancer》2007,10(4):234-240
Background Orotate phosphoribosyltransferase (OPRT; EC 2.4.2.10), a key enzyme that catalyzes one of the primary steps in the phosphorylation
of fluoropyrimidine, was recently recognized as an important enzyme that determines the anticancer effects of the dihydropyrimidine
dehydrogenase-inhibitory fluoropyrimidine, S-1.
Methods Levels of OPRT were examined in 97 gastric carcinoma tissues and 65 normal gastric mucosa tissues obtained from patients with
gastric carcinoma. The relation between OPRT levels and clinicopathological variables was evaluated, and correlations of OPRT
with thymidylate synthase and dihydropyrimidine dehydrogenase levels in gastric carcinoma tissues were evaluated.
Results Although OPRT levels were high in well-differentiated and localized carcinomas, they were not correlated with other clinicopathological
variables or with the pathological stage of gastric carcinoma. Levels of OPRT were significantly higher in gastric carcinoma
tissue than in normal gastric mucosa. OPRT levels were not correlated with levels of either thymidylate synthase or dihydropyrimidine
dehydrogenase. In samples of gastric carcinoma tissues and normal gastric mucosa tissues obtained simultaneously from 24 patients,
no correlation was found between OPRT levels in gastric carcinoma and levels in normal gastric mucosa.
Conclusion These results suggest that the OPRT level is significantly higher in gastric carcinoma tissue than in normal gastric mucosa
and that the OPRT level in gastric carcinoma is a novel variable that is independent of the levels of other previously known
enzymes related to 5-fluorouracil (FU) metabolism. 相似文献
67.
Yasuyuki Matsushita Yasufumi Kuroda Shinpei Niwa Satoshi Sonehara Chikuma Hamada Isao Yoshimura 《Drug safety》2007,30(8):715-726
BACKGROUND AND OBJECTIVE: Several statistical methods exist for detecting signals of potential adverse drug reactions in spontaneous reporting databases. However, these signal-detection methods were developed using regulatory databases, which contain a far larger number of adverse event reports than the databases maintained by individual pharmaceutical manufacturers. Furthermore, the composition and quality of the spontaneous reporting databases differ between regulatory agencies and pharmaceutical companies. Thus, the signal-detection criteria proposed for regulatory use are considered to be inappropriate for pharmaceutical industry use without modification. The objective of this study was to revise the criteria for signal detection to make them suitable for use by pharmaceutical manufacturers. METHODS: A model comprising 40 drugs and 1000 adverse events was constructed based on a spontaneous reporting database provided by a pharmaceutical company and used in a simulation to investigate appropriate criteria for signal detection. In total, 1000 pseudo datasets were generated with this model, and three statistical methods (proportional reporting ratio [PRR], Bayesian Confidence Propagation Neural Network [BCPNN] and multi-item gamma Poisson shrinker [MGPS]) for signal detection were applied to each dataset. The sensitivity and specificity of each method were evaluated using these pseudo datasets. The optimum critical value for signal detection (i.e. the value that achieved the highest sensitivity with 95% specificity) was identified for each method. The optimum values were also examined with the adverse events classified into two categories according to frequency. The three original detection methods and their revised versions were applied to a real pharmaceutical company database to detect 173 known adverse reactions of four drugs. RESULTS: The 1000 pseudo datasets consisted of an average of 81 862 reports and 11,407 drug-event pairs, including 1192 adverse drug reactions. The sensitivities of PRR, BCPNN and MGPS methods were 49%, 45% and 26%, respectively, whereas their specificities were 95%, 99.6% and 99.99%, respectively; these sensitivities were unacceptably low for pharmaceutical manufacturers, whereas the specificities were acceptable. The highest sensitivity for each method, obtained by changing critical values and maintaining specificity at 95%, was 44%, 62% and 62%, respectively. When adverse events were classified into two categories, sensitivities as high as 75% for regular events and 39% for rare events were achieved with the revised BCPNN method. The critical values of the information component minus two standard deviations (IC - 2SD) index of the revised BCPNN method were greater than -0.7 for regular events and greater than -0.6 for rare events. The revised BCPNN method yielded 51% sensitivity and 89% specificity for the real dataset. CONCLUSION: A lower critical value may be needed when signal-detection methodology is applied to the spontaneous reporting databases of pharmaceutical manufacturers. For example, it is recommended that pharmaceutical manufacturers use the BCPNN method with IC - 2SD criteria of greater than -0.7 for regular events and greater than -0.6 for rare events. 相似文献
68.
p53 Mutation in B-Cell Lymphoid Neoplasms with Reference to Oncogene Rearrangements Associated with Chromosomal Translocations 总被引:1,自引:1,他引:1
Takashi Akasaka Mikiko Muramatsu Norimitsu Kadowaki Hitoshi Ohno Kanji Ishizaki Hirohiko Yamabe Shirou Fukuhara Minoru Okuma 《Cancer science》1996,87(9):930-937
We investigated mutations of the p53 tumor suppressor gene in B-cell lymphoid neoplasms with reference to oncogene rearrangements associated with specific chromosomal translocations. These included 15 patients with a BCL1/PRAD1 gene rearrangement and/or PRAD1 overexpression, 45 with a BCL2 rearrangement, 2 with a BCL3 rearrangement, 24 with a BCL6 rearrangement, and 6 with both BCL2 and BCL6 rearrangements. Thirty-six patients lacked detectable oncogene rearrangements. Genomic DNA was isolated from involved tissues or leukemic cells obtained at diagnosis and/or at relapse, and established cell lines. Polymerase chain reaction-mediated single-strand conformation polymorphism analysis and direct sequencing were performed to analyze abnormalities of the p53 gene. We detected p53 gene alterations in 18 of 128 patients, representing 21 of the total 151 materials analyzed. In the total of 66 patients with an oncogene rearrangement studied at diagnosis, only one had a mutation; however, 6 of 37 patients studied at relapse showed p53 mutations. Sequential analysis revealed that the p53 mutation was closely associated with transformation from follicular lymphoma to large cell lymphoma, exclusively in BCL2 -positive lymphoma cases. Two of 13 mutations observed in oncogene rearrangement-positive cases and cell lines were transitions at CpG dinucleotides. In contrast, the relationship between p53 mutations and clinical behavior in oncogene rearrangement-negative cases was variable; 5 patients including one with indolent follicular lymphoma were positive for p53 mutation at initial presentation, and 2 of the 5 showed prolonged disease-free survival. Our findings suggest that p53 alteration exhibits diverse functions in the development and progression of B-cell tumors related to the presence or absence of oncogene rearrangement, and that chemotherapy-related influences may be involved in the occurrence of progression-associated p53 mutations. 相似文献
69.
70.